AIM: To evaluate the clinical effects of phacoemulsification combined the foldable intraocular lens implantation on patients with myopia and cataract.

METHODS:This study evaluated 62 eyes of 41 patients with myopia and cataract who received phacoemulsification combined the foldable intraocular lens implantation, and the intraoperative and postoperative complications, postoperative visual acuity were observed. The follow-up time was from 1 month to 6 months, average 3 months.

RESULTS: Posterior capsule rupture postoperatively occurred in 3 eyes and no other intraoperative complications. The first day after surgery, the uncorrected visual acuity of <0.1 were in 7 eyes(11%), 0.1≤visual acuity<0.5 in 42 eyes(68%), visual acuity≥0.5 in 13 eyes(21%); follow-up 3 months, the uncorrected visual acuity <0.1 were in 4 eyes(6%), 0.1≤ visual acuity<0.5 in 40 eyes(65%), visual acuity≥0.5 in 18 eyes(29%). The best-corrected visual acuity <0.1 were in 2 eyes(3%), 0.1≤visual acuity<0.5 in 36 eyes(58%), visual acuity≥0.5 in 24 eyes(39%), in the follow-up posterior lens capsule opacity was in 3 eyes(5%), without retinal detachment, choroidal detachment and macular edema.

CONCLUSION: It is safe and effective for high myopia with cataract to implant a foldable intraocular lens after phacoemulsification.